Shortage of Pancreatic enzyme replacement therapy (PERT) - Additional actions
Status in the CAS report: NOT ACKNOWLEDGED
Alert summary written by this siteSupplements NatPSA/2024/007/DHSC. Continued limited Creon supplies through 2026.
National Patient Safety Alerts
HOUNSLOW AND RICHMOND COMMUNITY HEALTHCARE NHS TRUST
ODS code RY9
Region LONDON
Open alerts 11
CAS snapshot 2 Sep 2026
MHRA Central Alerting System compliance report ↗ All National Patient Safety Alerts
National Patient Safety Alerts recorded as open for this trust after their completion deadline had passed, drawn from the MHRA Central Alerting System compliance report of 2 September 2026. That report names only organisations past a deadline, so it records neither compliance nor the position since that snapshot.
Open alerts for this trust 11
Discontinuation of Promixin (colistimethate) 1-million unit powder for nebuliser solution unit dose vials
Status in the CAS report: NOT ACKNOWLEDGED
Alert summary written by this sitePromixin colistimethate inhalation powder phased out May 2025. Ensure continuity of care.
Shortage of bumetanide 1mg tablets
Status in the CAS report: NOT ACKNOWLEDGED
Alert summary written by this siteBumetanide 1mg tablets stock depletion through mid-August 2025. Furosemide available as alternative.
Shortage of Antimicrobial Agents Used in Tuberculosis (TB) Treatment
Status in the CAS report: NOT ACKNOWLEDGED
Potential contamination of non-sterile alcohol-free skin cleansing wipes with Burkholderia spp: measures to reduce patient risk
Status in the CAS report: NOT ACKNOWLEDGED
Alert summary written by this siteUK-wide Burkholderia stabilis outbreak linked to contaminated skin cleansing wipes.
Supply of Licensed and Unlicensed Epidural Infusion Bags
Status in the CAS report: NOT ACKNOWLEDGED
Alert summary written by this siteEpidural bag supply issues from Sandoz and Fresenius Kabi expected until at least March 2026.
Recall of Quetiapine Oral Suspension (unlicensed medicine), manufactured by Eaststone Limited due to a potential for overdosing
Status in the CAS report: NOT ACKNOWLEDGED
Alert summary written by this siteQuetiapine oral suspension contains double the intended active ingredient (166 units, Oct 2025-Jan 2026). Cease distribution.
Steriflex No. 109 (1L) and No. 171 (2L): Potassium Chloride 0.15%, Sodium Chloride 0.45%, Glucose 2.5% Bags
Status in the CAS report: NOT ACKNOWLEDGED
Alert summary written by this siteFresenius Kabi transitioning to DEHP-free IV bags with supply shortages through September 2026.
Harm from delayed administration of rasburicase for tumour lysis syndrome
Status in the CAS report: NOT ACKNOWLEDGED
Alert summary written by this sitePrevent delays in administering rasburicase for tumour lysis syndrome. Ideally given within one hour in high-risk cases.
Shortage of dinoprostone 3mg vaginal tablets and 1mg/2.5ml, 2mg/2.5ml vaginal gel
Status in the CAS report: NOT ACKNOWLEDGED
Alert summary written by this sitePfizer has advised that quality issues affecting the raw materials used in manufacturing have resulted in supply interruptions for their Prostin ® E2 (dinoprostone) range, as follows: Prostin ® E2 3 mg vaginal tablets (pessary): unavailable until October 2026 Prostin …
Risk associated with adult breathing circuits lacking a patent exhalation route
Status in the CAS report: NOT ACKNOWLEDGED
Alert summary written by this siteDevelop local guidance for assembling breathing circuits, implement staff training on safety checks.
Data from the MHRA Central Alerting System compliance report of 2 September 2026, which lists alerts that had passed their completion deadline and remained open at that date. The Central Alerting System does not publish a list of compliant organisations, and the report says nothing about the position since that snapshot.